Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy
NCT04058366
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
251
Enrollment
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
ELX/TEZ/IVA
DRUG:
IVA
Sponsor
Vertex Pharmaceuticals Incorporated